Latest Breaking News On - Updated safety - Page 1 : comparemela.com

Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress

Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSteven steinEuropean hematology associationEuropean medicines agencyMyeloproliferative neoplasms biology translational researchDrug administrationExchange commissionIncyte corporationAmerican society of clinical oncologyMyeloproliferative neoplasms biology transitional researchXencor incLymphoma biology translational researchClinical oncologyAnnual meetingChief medical officerSelect advanced solid tumors

AstraZeneca advances scientific leadership in hematology at ASH 2023

CALQUENCE six-year follow-up data reinforce long-term benefit in chronic lymphocytic leukemia, and data across multiple hematology assets showcase breadth of promising early pipeline New,.

United kingdomUnited statesSan diego convention centerSan diegoAnas younesGianluca pirozziDiego marinaLiud acalabrutinibHallb manchesterNational studyAlexion pharmaceuticals incPatients of the internationalAstrazeneca pharmaceuticalsLymphoma groupA analysis utilizing electronic health recordsHead of development

Innate Pharma Announces New Clinical Data for Lacutamab and SAR443579/IPH6101 at ASH 2023

MARSEILLE, France (BUSINESS WIRE) Nov 3, 2023

United statesSan diegoSan diego convention centerHenry wheelerArthur rouillResearch collaborationAmerican society of hematology annual meetingCompany annual report on formExchange commissionFrench financial markets authorityEuronext parisAmerican societyAnnual meetingObjective response rateBenefit rateSezary syndrome

Innate Pharma SA: Innate Pharma Announces New Clinical Data for Lacutamab and SAR443579/IPH6101 at ASH 2023

Innate Pharma SA: Innate Pharma Announces New Clinical Data for Lacutamab and SAR443579/IPH6101 at ASH 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan diego convention centerSan diegoArthur rouillHenry wheelerAmerican society of hematology annual meetingResearch collaborationExchange commissionCompany annual report on formFrench financial markets authorityEuronext parisAmerican societyAnnual meetingObjective response rateBenefit rateSezary syndrome

Karyopharm To Present Data from Phase 1 Study of Selinexor in Patients with Treatment-Naïve Myelofibrosis at AACR and to Host Investor Webcast on April 18th

/PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it.

United statesSouth koreaKyongsang buktoUnited kingdomHong kongPrnewswire karyopharm therapeutics incKaryopharm selective inhibitor of nuclear exportDrug administrationAmerican association for cancer researchKaryopharm therapeutics incInformation departmentEuropean unionExchange commissionSelective inhibitor of nuclear exportUpdated safetyEfficacy data will